Researchers say they are closer to solving the mystery of how a good night’s sleep protects against heart disease. In studies using mice, they discovered a previously unknown mechanism between the brain, bone marrow, and blood vessels that appears to protect against the development of atherosclerosis, or hardening of the arteries—but only when slee...
In a study partly funded by NHLBI, a team of researchers found a 25 percent reduction in the risk of cardiovascular disease among participants who consumed a Mediterranean-type diet rich in plants and olive oil and low in meats and sweets.
Researchers find link between atrial fibrillation and mutations in a gene associated with heart disease
Researchers have discovered a new link between atrial fibrillation (Afib)—a potentially life-threatening condition that causes rapid, irregular heartbeat—and mutations in a gene associated with heart disease.
Findings reveal tripling of blood levels of TMAO from red meat diet, but dietary effects can be reversed Researchers have identified another reason to limit red meat consumption: high levels of a gut-generated chemical called trimethylamine N-oxide (TMAO), that also is linked to heart disease. Scientists found that people who eat a diet rich in red...
Treatment of sleep disorder might help improve blood pressure control in this high-risk group African-Americans with moderate or severe sleep apnea are twice as likely to have hard-to-control high blood pressure when their sleep apnea goes untreated, according to a new study funded mainly by the National Heart, Lung, and Blood Institute (NHLBI), pa...
A team of NHLBI-funded scientists have cut out a segment of cells’ genomes that is the main reason for an increased risk of cardiovascular diseases, which include heart attacks, aneurysms or strokes, according to a study published in Cell.
Researchers have discovered that a type of tiny marine invertebrate has a blood-forming system and an immune system with remarkable similarities to humans
WHAT: A scientist from the National Institutes of Health will present promising, early results from a human clinical trial testing a novel gene replacement therapy in people with severe sickle cell disease. Preliminary findings suggest that the approach has an acceptable level of safety and might help patients consistently produce normal red blood...
Credit: Jill George, NIH
An NHLBI researcher shared encouraging results from a human clinical trial testing a novel gene replacement therapy in people with severe sickle cell disease.
Researchers funded by NHLBI established that rotating night shift work combined with an unhealthy lifestyle significantly increase the risk of type 2 diabetes in women.
A daily hydroxyurea pill has proven safe and effective for young children living with sickle cell disease in sub-Saharan Africa, where the condition is far more prevalent.